Published in Medical Imaging Week, July 10th, 2004
Radiologists in Germany conducted a study "to evaluate in vitro and in vivo imaging of HER-2-overexpressing tumors using near-infrared optical imaging."
"A fluorochrome probe was designed by coupling Cy5.5 to anti-HER-2 antibodies," explained I. Hilger and coauthors working at Friedrich Schiller University Hospital in Jena. "Cells overexpressing (SK-BR-3 cells) or normally expressing (PE/CA-PJ34 cells) the HER-2 protein were incubated with the probe. After removing unbound probe molecules, fluorescence intensities were determined (a.u.: arbitrary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week
Source: Medical Imaging Week (2004-07-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.